Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Low-grade Serous Ovarian Cancer × binimetinib × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 3 Pancreatic Neoplasms 2 Fallopian Tube Neoplasms 2 Triple Negative Breast Neoplasms 1 Neoplasm Metastasis 1 Low-grade Serous Ovarian Cancer 1 Endometrial Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01849874 2023-10-30

A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

Pfizer

Phase 3 Terminated

341 enrolled 15 charts

Low-grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡